(Q69360066)
Statements
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2 (English)
J C Wang
A Walle
A Novogrodsky
M Suthanthiran
R T Silver
N H Bander
A L Rubin
K H Stenzel
1 December 1989